Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 87255

1 recalled-product record grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
January 21, 2021
Product types
Drug
Classifications
Class II
Statuses
Terminated
Recalling firm wording
Stanley Specialty Pharmacy Compounding and Wellness Center

Dossier provenance

Source snapshots represented here

  • openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

1 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 1

Lidocaine/Tetracaine (LIPO110)* 23%/7% Ointment 100 GMS per 4 ounce plastic ointment jar, Rx Only, Stanley Specialty Pharmacy 3120 Latrobe Dr. Suite 200 Charlotte, NC 28211

D-0252-2021
Recall number
D-0252-2021
Initiated
January 21, 2021
Classification
Class II
Status
Terminated
Quantity
4400 grams (44 jars)

App-derived interpretation

Potency or specification failure reason.potency_specification_failure · v1.0.0
Superpotent

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Superpotent Drug. Lidocaine higher concentration than listed

Code information

Lot: 195789 Exp. Apr. 17 2021

Distribution pattern

Distributed Nationwide in the USA